Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2017.09.30
2017年第四次暂时股东大会决议通告
2017.09.26
关于公司股票复牌的通告
2017.09.26
关于刊行股份购置资产暨关联生意报告书修订说明的通告
2017.09.26
关于深圳证券生意所重组问询函之回复
2017.09.26
中天堂富证券有限公司关于深圳证券生意所《关于对Z6尊龙的重...
2017.09.26
北京市中伦状师事务所关于公司刊行股份购置资产暨关联生意的增补执法意见书
2017.09.26
刊行股份购置资产暨关联生意报告书(草案)
2017.09.26
刊行股份购置资产暨关联生意报告书(草案)摘要
2017.09.20
关于妄想刊行股份购置资产的停牌希望通告
2017.09.13
关于妄想刊行股份购置资产的停牌希望通告
第一页
上一页
64
65
66
67
68
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】